Literature DB >> 6111031

Degradation of prolylleucylglycinamide (MIF) by mouse brain.

A Neidle, N Yessaian, A Lajtha.   

Abstract

Prolylleucylglycinamide (MIF) at 1.0 mM concentration and pH 7.0 was hydrolyzed by mouse brain homogenate at a rate of 140 nmol/mg protein/hr. Nearly all of this activity can be accounted for by the action of two enzymes, both of which cleave Pro and Leu sequentially from the N-terminus of MIF. At pH 7.0 the predominant enzyme is arylamidase, inhibited by puromycin (1 mM) and Mn2+ (2.5 mM). At pH 8.5, in the presence of Mn2+, a second enzyme with a higher potential activity (570 nmol/mg protein/hr) was observed. While the arylamidase is primarily localized in the cytosol, the Mn2+-stimulated enzyme is equally divided between soluble and particulate fractions. Because of its ability to cleave leucinamide, its high pH optimum, and its Mn2+ dependence, it can be classified as a leucine aminopeptidase (LAP). In its substrate specifically and its preference for Mn2+ over Mg2+ it resembles the LAP from connective tissue more than that from other sources.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6111031     DOI: 10.1007/bf00966139

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

1.  Monkey brain arylamidase. II. Further characterization and studies on mode of hydrolysis of physiologically active peptides.

Authors:  M Hayashi
Journal:  J Biochem       Date:  1978-12       Impact factor: 3.387

2.  The purification of a bovine kidney enzyme which cleaves melanocyte-stimulating hormone-release inhibiting factor.

Authors:  M A Khilji; G S Bailey
Journal:  Biochim Biophys Acta       Date:  1978-11-10

Review 3.  CNS effects of peripherally administered brain peptides.

Authors:  A J Kastin; R D Olson; A V Schally; D H Coy
Journal:  Life Sci       Date:  1979-07-30       Impact factor: 5.037

4.  Inactivation of melanocyte-stimulating hormone release-inhibiting factor by a manganese-stimulated bovine brain aminopeptidase.

Authors:  W H Simmons; A S Brecher
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

5.  Inactivation studies of angiotensin II by purified enzymes.

Authors:  L Abrash; R Walter; N Marks
Journal:  Experientia       Date:  1971

6.  Peptide hydrolases in mammalian connective tissue. I. Survey of activities and preliminary characterization of certain peptidases.

Authors:  C Schwabe
Journal:  Biochemistry       Date:  1969-03       Impact factor: 3.162

7.  Partial resolution of brain arylamidases and aminopeptidases.

Authors:  N Marks; R K Datta; A Lajtha
Journal:  J Biol Chem       Date:  1968-06-10       Impact factor: 5.157

8.  Peptide hydrolases in mammalian connective tissue. II. Leucine aminopeptidase. Purification and evidence for subunit structure.

Authors:  C Schwabe
Journal:  Biochemistry       Date:  1969-03       Impact factor: 3.162

9.  Isolation and characterization of an enkephalin-degrading aminopeptidase from rat brain.

Authors:  H P Schnebli; M A Phillipps; R K Barclay
Journal:  Biochim Biophys Acta       Date:  1979-07-11

10.  Brain arylamidase. Purfication and characterization of the soluble bovine enzyme.

Authors:  A S Brecher; J B Suszkiw
Journal:  Biochem J       Date:  1969-04       Impact factor: 3.857

View more
  1 in total

1.  An opiate receptor-associated aminopeptidase that degrades enkephalins.

Authors:  K S Hui; T Gioannini; M Hui; E J Simon; A Lajtha
Journal:  Neurochem Res       Date:  1985-08       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.